- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.12.24 | Edgewise's skeletal myosin inhibitor reduces biomarker in phase 2 muscular dystrophy trial | ||
| 16.12.24 | PureTech's lung fibrosis drug slows decline in phase 2 trial | ||
| 16.12.24 | Pharming pays $66M for Abliva and its 'potential blockbuster' mitochondrial disease med | ||
| 13.12.24 | Incyte scraps anemia program after drug fails to improve symptoms in rare blood cancer | ||
| 13.12.24 | Medtronic's latest ingestible PillCam completes first patient GI procedure | ||
| 13.12.24 | AbbVie buys Roche spinout Nimble Therapeutics for $200M | ||
| 13.12.24 | BeiGene inks $150M deal to follow cancer combo trail blazed by Amgen and Ideaya | ||
| 13.12.24 | Eisai unit hands over $46M for Japanese rights to Newron's schizophrenia add-on | ||
| 13.12.24 | Chutes & Ladders-AI firm Xaira powers up C-suite with pharma vet | ||
| 13.12.24 | Boundless Bio drops clinical-stage cancer drug over phase 1 data, shakes up C-suite | ||
| 13.12.24 | Gilead's O'Day relishes Berger reunion as cancer specialist agrees to join from Sanofi | ||
| 13.12.24 | Editas lays off 65% of staff, including CMO, after fruitless search for reni-cel partner | ||
| 12.12.24 | iTeos deprioritizes cancer candidate despite 'encouraging' phase 2 data | ||
| 12.12.24 | FDA expands use of J&J's Impella heart pumps to pediatric patients | ||
| 12.12.24 | Evotec, Novo Nordisk's drug discovery accelerator debuts first 3 projects, adds 5 partners | ||
| 12.12.24 | PeptiDream's macrocyclic peptides preserve muscle mass in mice given semaglutide | ||
| 12.12.24 | Tenpoint, Visus merge in effort to push presbyopia-correcting eye drop over FDA finish line | ||
| 12.12.24 | Elevation lifts HER3 ADC toward clinic with $368M Synaffix deal | ||
| 12.12.24 | Corcept's cortisol modulator fails to slow ALS decline, linked to 'gastrointestinal upset' at onset | ||
| 12.12.24 | Multiomics startup Pleno raises $25M for commercial launch, plucks new CEO from Illumina | ||
| 12.12.24 | Keros' stock tanks after halting 2 arms of hypertension trial over fluid buildups around heart | ||
| 12.12.24 | Industry M&A volume declined 8% this year compared to '23: PwC | ||
| 11.12.24 | Bavarian Nordic plans to shut down San Diego R&D site, lay off 48 employees | ||
| 11.12.24 | Reverse, reverse: Liver disease biotech Hepion and Pharma Two B call off merger | ||
| 11.12.24 | USPSTF endorses HPV self-collection tests for cervical cancer screening |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
